NXGN Stock Overview
NextGen Healthcare, Inc. provides healthcare technology solutions in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for NXGN from our risk checks.
NextGen Healthcare, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$23.94 |
| 52 Week High | US$23.98 |
| 52 Week Low | US$15.23 |
| Beta | 0.77 |
| 11 Month Change | 0.46% |
| 3 Month Change | 41.66% |
| 1 Year Change | 19.28% |
| 33 Year Change | 52.97% |
| 5 Year Change | 51.04% |
| Change since IPO | 13,828.73% |
Recent News & Updates
Recent updates
Is There An Opportunity With NextGen Healthcare, Inc.'s (NASDAQ:NXGN) 49% Undervaluation?
Aug 24
NextGen Healthcare, Inc. Just Recorded A 16% EPS Beat: Here's What Analysts Are Forecasting Next
Jul 27Investors Will Want NextGen Healthcare's (NASDAQ:NXGN) Growth In ROCE To Persist
Jul 13We Think NextGen Healthcare (NASDAQ:NXGN) Can Manage Its Debt With Ease
Jun 08Calculating The Fair Value Of NextGen Healthcare, Inc. (NASDAQ:NXGN)
May 19What Does NextGen Healthcare, Inc.'s (NASDAQ:NXGN) Share Price Indicate?
Mar 14We Think NextGen Healthcare (NASDAQ:NXGN) Can Manage Its Debt With Ease
Feb 27Is NextGen Healthcare, Inc. (NASDAQ:NXGN) Expensive For A Reason? A Look At Its Intrinsic Value
Dec 08These Return Metrics Don't Make NextGen Healthcare (NASDAQ:NXGN) Look Too Strong
Oct 27At US$17.85, Is It Time To Put NextGen Healthcare, Inc. (NASDAQ:NXGN) On Your Watch List?
Sep 30NextGen Enterprise solution to be used by NY-based health center
Sep 28NextGen Healthcare, Inc.'s (NASDAQ:NXGN) Intrinsic Value Is Potentially 75% Above Its Share Price
Sep 07NextGen Healthcare (NASDAQ:NXGN) Is Finding It Tricky To Allocate Its Capital
Jul 29NextGen Healthcare Non-GAAP EPS of $0.16 in-line, revenue of $153.3M in-line, 2023 revenue outlook below estimates
Jul 26Is It Too Late To Consider Buying NextGen Healthcare, Inc. (NASDAQ:NXGN)?
May 17NextGen At A Crossroads
Oct 13Is There An Opportunity With NextGen Healthcare, Inc.'s (NASDAQ:NXGN) 44% Undervaluation?
Jun 29Shareholder Returns
| NXGN | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | 0.04% | -8.3% | -1.0% |
| 1Y | 19.3% | 5.7% | 30.3% |
Return vs Industry: NXGN exceeded the US Healthcare Services industry which returned -7.8% over the past year.
Return vs Market: NXGN exceeded the US Market which returned 14.1% over the past year.
Price Volatility
| NXGN volatility | |
|---|---|
| NXGN Average Weekly Movement | 5.2% |
| Healthcare Services Industry Average Movement | 8.1% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: NXGN's share price has been volatile over the past 3 months.
Volatility Over Time: NXGN's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1974 | 2,783 | David Sides | www.nextgen.com |
NextGen Healthcare, Inc. provides healthcare technology solutions in the United States. The company offers clinical care solutions, including NextGen Enterprise EHR; financial solutions, such as NextGen Enterprise PM; patient engagement solutions comprising NextGen Virtual Visits; integrated clinical care and financial solutions consisting of NextGen Office; interoperability solutions that include NextGen Share and Mirth Connect; data and analytics solutions, which comprise NextGen Health Data Hub; and value based care solutions, including NextGen Population Health Solutions. It also provides managed services, such as revenue cycle management services comprising billing and collections, electronic claims submission and denials management, electronic remittance and payment posting, and accounts receivable follow-up; and client and support services.
NextGen Healthcare, Inc. Fundamentals Summary
| NXGN fundamental statistics | |
|---|---|
| Market cap | US$1.61b |
| Earnings (TTM) | -US$6.21m |
| Revenue (TTM) | US$695.05m |
2.3x
P/S Ratio-258.5x
P/E RatioIs NXGN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NXGN income statement (TTM) | |
|---|---|
| Revenue | US$695.05m |
| Cost of Revenue | US$344.33m |
| Gross Profit | US$350.73m |
| Other Expenses | US$356.94m |
| Earnings | -US$6.21m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.093 |
| Gross Margin | 50.46% |
| Net Profit Margin | -0.89% |
| Debt/Equity Ratio | 63.2% |
How did NXGN perform over the long term?
See historical performance and comparison